They seem to be drugs of choice in metabolic control of diabetes and possibly nephroprotection in patients with T2D and advanced CKD who still do not need insulin (only a handful of antihyperglycemic agents may be used in CKD stages 4 and 5, including insulin). Here, INS is linked to type 2 diabetes mellitus.